Interview with Erik Haeffler, CEO, APL

APL (Apotek Produktion & Laboratorier AB) is a Swedish state-owned company with a public policy assignment to develop, manufacture and supply unlicensed sterile and non-sterile pharmacy compounding products for patients with additional needs, both as individually tailored extemporaneous medicines and as batch-manufactured stock formulations. They aim to provide treatments for patients with additional needs who cannot use readily available medication. This is done in close collaboration with specialists, prescribers and authorities. The assignment also comprises preparedness to maintain operations in times of crisis.

In this video Erik speaks about the CurifyLabs CSS-technology.